Hi gaboy, I'd rather keep the discussions of nss and

New Post Public Reply Private Reply Replies (0) Message Board
Big Tuna gaboy47 #2335

Hi gaboy,

I'd rather keep the discussions of nss and criminal manipulation off this board. For those interested in learning more on the topic, I could give you the appropriate sites to visit. Just send me a PM. I will simply answer with the following, though:

There's nothing one can do about the manipulation of the OTC markets. It's a market that was designed by the crooks for the consistent and methodic theft from the investing public under the watch (or non-watch) of the SEC. Fact of the matter is that most of the shares one owns in an acct are 'share entitlements' which normally means 'air shares' or nss. Sending in anything to the SEC is an absolute waste of time when it comes to nss. Most of the OTC stocks are shorted well beyond the OS, and most nss will never cover due to lack of enforcement. The only way a company under attack by the criminals is when that underlying company finally becomes a capital company and/or is revenue producing. Don't expect the SEC to ever force a cover in this arena. If they did and word got out, there would probably be 10,000 companies standing in line waiting for the regulators to enforce an action for their stock. As an example, I assisted a forensic count of shares in an existing OTC company. This was done over a two week period. After all was said and done, the 27 largest shareholders owned almost two times the OS at the time. At the same time, there were almost 2,000 shareholders. We estimate the nss to be in excess of 1.3 billion shares still today. But to answer your question regarding sending the SEC anything, all I can suggest is to not waste your time. Nothing, I repeat NOTHING, will ever lead to an action. The nss crooks will stay short until they decide that it's no longer profitable for them to stay short. Should a company ever become capitalized and revenue producing, that's when a company begins to regain control of their share structure as it pertains to the massive fraud perpetrated on their stock. In the case of MPIX, it's probably no different than the majority of OTC stock. I do believe it's shorted, but I don't spend a lot of time on thinking about it. That's just how the OTC cesspool operates. In the meantime, if one believes in the huge potential, they should be thanking the crooks and scammers for keeping the stock down while accumulating on the cheap.

ZZYX/MPIX needs to execute, period. Then all will be fine as we'll be riding a great wave.

Mindpix Corporation (MPIX) Stock Research Links

MPIX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

AULUMU Unveils High-Design ADuo iPhone Case

Updated Category News Views 7

A Space-Aged Look for Everyday Use In the gadget world, appearances matter but durability matters more. So AULUMU rolls out the ADuo Particle Aramid Fiber Case for iPhone Duo, making a bold claim in the realm of tech accessories. The Backbone: Aramid Fiber Aramid fiber isn't your run-of-the-mill material. We're talking 1500D quality here—strong but feather-light, a...

Continue Reading
Qatar's Cultural Ventures Go Big Through 2030

Updated Category News Views 2

Cultural Partners Lined Up Well Ahead In the swirling world of cultural diplomacy, Qatar's got its eyes set way beyond the skyline with their Years of Culture initiative. Announced recently, they've lined up partners through 2030, locking hands with Italy, the Netherlands, Switzerland, Portugal, and Spain in the coming years. Such moves aren't just for show—they’re...

Continue Reading
TORL Bio's Ixo-V Drug Shows Promise in Combatting GCT

Updated Category News Views 4

A Beacon of Hope in Germ Cell Tumor Treatment There's something brewing in the oncology world that's worth a nod. TORL BioTherapeutics has rolled out some interesting preliminary data for their hopeful cancer buster, ixotatug vedotin, or Ixo-V. This study is part of a wider effort to take a swing at recurrent germ cell tumors (GCTs) with some tough results already making...

Continue Reading
GoDaddy Launches 'Ink Your Link' in NYC

Updated Category News Views 5

GoDaddy's Bold Stunt at the Big Apple In the noise of the New York Stock Exchange, everyone is abuzz with GoDaddy’s latest marketing push. Aptly titled 'Ink Your Link,' this campaign has NYC in its sights this weekend, targeting entrepreneurs and consumers alike. The plan is to open a unique pop-up in Manhattan where business owners can ink a temporary tattoo—a bold...

Continue Reading
SOCaaS Market Grows to $16.68B by 2031, What It Means

Updated Category News Views 9

SOC as a Service: More Than Just Jargon The term 'SOC as a Service' (SOCaaS) might sound like some alphabet soup, but it’s a serious contender in today’s digital security world. With projected growth from $9.04 billion in 2026 to a whopping $16.68 billion by 2031, the SOCaaS market isn’t just having a moment, it’s setting up a stage for the long haul. It’s like...

Continue Reading
Hyperliquid Expands Stock Buyback to $100 Million

Updated Category News Views 0

Diving Into Hyperliquid's $100 Million Bold Move Let’s cut through the corporate fluff—Hyperliquid Strategies Inc. just cranked up their stock repurchase program to a cool $100 million. Yep, that’s right—the brain trust behind NASDAQ:PURR has pulled out the checkbook to buy more of its own shares. This decision, unveiled on October 23, 2026, is like tossing a...

Continue Reading
Autoliv Sees Mixed Q3 2026 Amid Global Challenges

Updated Category News Views 4

An Uneven Road: Autoliv's Q3 2026 Chronicle You'd think by now everyone in the automotive game would have mastered the art of the pivot. Well, Autoliv seems to have gotten the memo for Q3 2026. Sales dipped slightly, yet their moves in Asia hint at a calculated gambit in a rough global landscape. Digging into the Numbers The financials were a mixed bag. Net sales huddled...

Continue Reading
Tragedy in Jordan: A Call for Unity and Support

Updated Category News Views 0

A Dark Day in Jordan It's a gut punch, hearing news of yet another brutal attack targeting the Christian community in Jordan's Karak province. This act of terror isn't just a regional dagger—it cuts deep into the fabric of shared humanity. On Friday, the tranquil air of a sacred gathering was shattered, leaving behind grief and a call to action for those who refuse to...

Continue Reading
Ractigen's LiCO™ Platform Hits Extrahepatic Milestones

Updated Category News Views 5

Breaking New Ground in RNA Therapeutics Hey, in the world of biotech, landing a meaningful delivery system is like striking gold, and it seems Ractigen Therapeutics just found a shiny nugget. Their latest study on the LiCO™ platform, living and breathing in the pages of Molecular Therapy - Nucleic Acids, maps out a path to some serious therapeutic territory. These guys...

Continue Reading
Savvy Moves: Avoiding Pitfalls When Buying Used Vans

Updated Category News Views 4

When you're eyeing a used work van, don't just kick the tires and jot down the mileage—there's a whole backyard BBQ checklist you need to chew through. Tony Collichio, the work van guru from Spencerport, lays it down for us, highlighting key questions to ask before pulling out the checkbook. And let me tell you, these aren’t your everyday 'how does it drive?' queries....

Continue Reading

Top 5 Most Recently Viewed Articles

Analyzing Blackbaud's Short Interest Trends and Market Sentiment

Updated Category News Views 254

Understanding Blackbaud's Short Interest Dynamics Blackbaud's short interest, which refers to stocks that are sold short but not yet repurchased, has seen a notable decrease of 6.58% according to the latest report. This decline is intriguing given its critical role in investment strategies. Currently, the company has 613,000 shares sold short, making up approximately...

Continue Reading
ECARX Reports Strong Financial Performance for 2024

Updated Category News Views 180

ECARX Holdings Inc. Overview ECARX Holdings Inc. (NASDAQ: ECX), a pioneering global mobility technology provider, recently published its unaudited financial results for 2024. The year marked a remarkable journey for the company, demonstrating considerable growth and strategic advancement in the automotive technology sector. Highlights of 2024 Financial Performance Strong...

Continue Reading
Emerging Cancer Treatment Innovations Transform Patient Care

Updated Category News Views 282

Innovative Approaches in Cancer Treatment The landscape of cancer treatment is rapidly evolving, with breakthroughs that are reshaping how we approach various forms of this complex disease. Major pharmaceutical companies are making waves with new survival data and innovative lung cancer treatments that leverage distinct mechanisms. These advancements represent a shift in...

Continue Reading
Peter Schiff Raises Concerns Over MicroStrategy's Debt Moves

Updated Category News Views 285

Peter Schiff Questions MicroStrategy's Financial Strategy Economist and market analyst Peter Schiff recently expressed doubts regarding MicroStrategy Inc’s MSTR approach to convertible debt offerings. His comments raise alarms about possible financial instability, especially for companies heavily invested in Bitcoin. Recent Market Behavior Despite a 2.5% rise in...

Continue Reading
Strategic Expansion: Harbor Group International's Latest Acquisition

Updated Category News Views 235

Harbor Group International's Commitment to Growth Harbor Group International, LLC (HGI), a dedicated real estate investment and management firm, has made a significant move in their strategy by acquiring Reflections, a multifaceted community that adds substantial value to their existing portfolio. A Strategic Acquisition HGI has successfully completed an acquisition...

Continue Reading